Inspire Medical Systems
INSP
286 hedge funds and large institutions have $5.01B invested in Inspire Medical Systems in 2022 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 98 increasing their positions, 114 reducing their positions, and 43 closing their positions.
1.58% more ownership
Funds ownership: 97.85% → 99.43% (+1.6%)
3% more call options, than puts
Call options by funds: $70M | Put options by funds: $67.7M
4% less funds holding
Funds holding: 298 → 286 (-12)
14% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 114
19% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 43
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
23% less capital invested
Capital invested by funds: $6.52B → $5.01B (-$1.51B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$56.7M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$52.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$47.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.8M |
| 5 |
KeyBank National Association
Cleveland,
Ohio
|
+$32.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$68.8M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$44.8M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$42M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$22.6M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$22.3M |
INSP Hedge Fund Activity: Q2 2022 in Review
286 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q2 2022, worth a combined $5.01B — down 23% from $6.52B a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of INSP and 35 opened new positions — a net loss of 8 holders — while 114 trimmed existing stakes and 98 added.
The largest buyer was Viking Global Investors, adding an estimated $56.7M. The largest seller was Fred Alger Management, cutting an estimated $68.8M.
- 286 institutional investors held Inspire Medical Systems (INSP) as of Q2 2022, down from 298 in Q1 2022.
- Funds reported $5.01B of Inspire Medical Systems stock for Q2 2022, down 23% quarter-over-quarter.
- 35 funds opened new Inspire Medical Systems positions in Q2 2022 and 43 closed out, a net change of -8 holders.
- The largest Inspire Medical Systems buyer in Q2 2022 was Viking Global Investors, an estimated $56.7M added.
- The largest Inspire Medical Systems seller in Q2 2022 was Fred Alger Management, an estimated $68.8M sold.
Based on aggregated 13F filings for Q2 2022.